Angiodynamics Overview

  • Founded
  • 1988
Founded
  • Status
  • Public
  • Employees
  • 800
Employees
  • Stock Symbol
  • ANGO
Stock Symbol
  • Investments
  • 14
  • Share Price
  • $24.63
  • (As of Monday Closing)

Angiodynamics General Information

Description

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 14 Plaza Drive
  • Latham
  • New York, NY 12110
  • United States
+1 (518) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiodynamics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$24.63 $24.30 $8.05 - $25.25 $939M 38M 299K -$4.42

Angiodynamics Financials Summary

In Thousands,
USD
TTM 28-Feb-2021 FY 2020 31-May-2020 FY 2019 31-May-2019 FY 2018 31-May-2018
EV 777,317 372,044 790,670 813,224
Revenue 272,500 264,157 270,634 261,655
EBITDA (144,464) (143,423) 16,277 8,962
Net Income (169,147) (166,787) 61,340 16,335
Total Assets 582,245 594,214 836,438 705,472
Total Debt 30,000 40,000 131,907 91,621
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angiodynamics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthca
Surgical Devices
New York, NY
800 As of 2020
000000 - 000

00000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
00000000000 0000000
Alameda, CA
0000 As of 0000
0000
0000 0000-00-00
00000000 0000

0000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
00000000 0000000
Princeton, NJ
0000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angiodynamics Competitors (52)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Penumbra Formerly VC-backed Alameda, CA 0000 0000 00000000 0000
0000000 0000000000 Corporation Princeton, NJ 0000 00000 000000 - 000 00000
00000000 0000000 Private Equity-Backed Minnetonka, MN 000 000000000000
00 000000 Formerly VC-backed Milpitas, CA 00 00000 000000&0 00000
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 000000000 - 00000
You’re viewing 5 of 52 competitors. Get the full list »

Angiodynamics Executive Team (16)

Name Title Board Seat Contact Info
James Clemmer Chief Executive Officer, President & Board Member
Stephen Trowbridge Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Chad Campbell Senior Vice President and General Manager, Vascular Access
Scott Centea Senior Vice President and General Manager, VIT
Tom Hensel Manager, Business Development
You’re viewing 5 of 16 executive team members. Get the full list »

Angiodynamics Board Members (12)

Name Representing Role Since
000000 000000 Angiodynamics Board Member, Chairman of the Audit Committee and Member of the Compensation Committee 000 0000
000000 0000 Angiodynamics Board Member 000 0000
000000 00000000 Angiodynamics Chairman of the Board 000 0000
00000 0000000 Angiodynamics Chief Executive Officer, President & Board Member 000 0000
000 0000 Angiodynamics Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Angiodynamics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiodynamics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (00 0000 0 07-Jan-2020 000000000 00000 00 Buildings and Property 00000 0000000
00000 03-Oct-2019 000000000000000000 0000 Surgical Devices 00000 0000000
000000000 21-Sep-2018 000000000000000000 0000 Therapeutic Devices 00000 0000000
00000000 000000000 15-Aug-2018 000000000 00000 00 000.00 Buildings and Property 00000 0000000
Merz (Distribution rights of Asclera) 10-Mar-2016 Corporate Asset Purchase Buildings and Property 000000 000000
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Angiodynamics Subsidiaries (4)

Company Name Industry Location Founded
Eximo Surgical Devices Rehovot, Israel 2012
00000000 0000000 Other Devices and Supplies Marlborough, MA 0000
000000000 Therapeutic Devices Houston, TX 0000
000000 Surgical Devices Andover, MA 0000
To view Angiodynamics’s complete subsidiaries history, request access »

Angiodynamics Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 (000000000000 10-Mar-2016 000000000 00000 00 Completed
  • 0000000000000
0000000000 01-Apr-2015 000000000 000 Completed
  • 0000000000000
AngioCare 01-Jan-2011 Merger/Acquisition Completed
To view Angiodynamics’s complete exits history, request access »